Published in Indian J Pharm Sci on September 01, 2013
The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. N Engl J Med (1999) 29.32
Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care (1986) 22.65
Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both. N Engl J Med (2003) 10.57
A multidisciplinary intervention to prevent the readmission of elderly patients with congestive heart failure. N Engl J Med (1995) 10.32
Guidelines for the diagnosis and treatment of chronic heart failure. Eur Heart J (2001) 5.77
Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: randomised trial--the Losartan Heart Failure Survival Study ELITE II. Lancet (2000) 5.42
The underutilization of cardiac medications of proven benefit, 1990 to 2002. J Am Coll Cardiol (2003) 3.26
The EuroHeart Failure Survey programme--a survey on the quality of care among patients with heart failure in Europe. Part 2: treatment. Eur Heart J (2003) 2.78
Chronic heart failure in Australian general practice. The Cardiac Awareness Survey and Evaluation (CASE) Study. Med J Aust (2001) 2.71
Noncompliance with congestive heart failure therapy in the elderly. Arch Intern Med (1994) 2.62
Self-care behaviors among patients with heart failure. Heart Lung (2002) 1.77
Factors influencing knowledge of and adherence to self-care among patients with heart failure. Arch Intern Med (1999) 1.77
Non-compliance in patients with heart failure; how can we manage it? Eur J Heart Fail (2005) 1.66
Relationship between psychosocial variables and compliance in patients with heart failure. Heart Lung (2001) 1.61
Non-compliance and knowledge of prescribed medication in elderly patients with heart failure. Eur J Heart Fail (1999) 1.59
Adherence to the medical regime in patients with heart failure. Eur J Heart Fail (2010) 1.51
Does encouraging good compliance improve patients' clinical condition in heart failure? Br J Clin Pract (1995) 1.45
Drug copayment and adherence in chronic heart failure: effect on cost and outcomes. Pharmacotherapy (2006) 1.41
Adherence to angiotensin-converting enzyme inhibitor therapy for heart failure. Prog Cardiovasc Nurs (2002) 1.08
Management of heart failure in Canadian long-term care facilities. Can J Cardiol (2004) 1.02
Adherence to drug treatment in association with how the patient perceives care and information on drugs. J Clin Nurs (2007) 0.93
Why do patients fail to receive beta-blockers for chronic heart failure over time? A "real-world" single-center, 2-year follow-up experience of beta-blocker therapy in patients with chronic heart failure. Am Heart J (2005) 0.84
Personal and social factors regarding medical non-compliance in cardiac failure patients. J Coll Physicians Surg Pak (2011) 0.80
Heart failure due to left ventricular systolic dysfunction: treatment at discharge from hospital and at one year. Int J Cardiol (2005) 0.77